Infinity Pharmaceuti Gross Profit is decreasing over the last several years with slightly volatile swings. Gross Profit is estimated to finish at about 1.6 M this year. During the period from 2010 to 2022 Infinity Pharmaceuti Gross Profit regressed destribution of quarterly values had coefficient of variationof 110.88 and r-squared of 0.51. Infinity Pharmaceuti Revenues is most likely to decrease significantly in the upcoming years. The last year's value of Revenues was reported at 1.55 Million. The current Research and Development Expense is estimated to increase to about 24.7 M, while Consolidated Income is projected to decrease to (50.2 M).
Infinity Historical Trends
Infinity
Gross Profit
Net Income Per Employee
Revenue Per Employee
Average Assets
Earnings Before Interest Taxes and Depreciation Amortization EBITDA
Earnings Before Interest Taxes and Depreciation Amortization USD
Earnings before Tax
Average Equity
Enterprise Value
Free Cash Flow
Invested Capital
Invested Capital Average
Market Capitalization
Tangible Asset Value
Working Capital
PPandE Turnover
Accounts Payable Turnover
Accrued Expenses Turnover
Operating Margin
Cash and Equivalents Turnover
Return on Investment
Cash Flow Per Share
Revenue to Assets
Total Assets Per Share
Quick Ratio
Net Current Assets as percentage of Total Assets
Asset Turnover
Book Value per Share
Current Ratio
Debt to Equity Ratio
EBITDA Margin
Earnings per Basic Share
Earnings per Diluted Share
Earnings per Basic Share USD
Enterprise Value over EBIT
Enterprise Value over EBITDA
Free Cash Flow per Share
Profit Margin
Price to Book Value
Price to Earnings Ratio
Price to Sales Ratio
Return on Average Assets
Return on Average Equity
Return on Invested Capital
Return on Sales
Sales per Share
Tangible Assets Book Value per Share
Capital Expenditure
Depreciation Amortization and Accretion
Net Cash Flow or Change in Cash and Cash Equivalents
Issuance Purchase of Equity Shares
Issuance Repayment of Debt Securities
Net Cash Flow from Financing
Net Cash Flow from Investing
Net Cash Flow Investment Acquisitions and Disposals
Showing smoothed Gross Profit of Infinity Pharmaceuti with missing and latest data points interpolated. Gross profit is a required income statement account that reflects total revenue of Infinity Pharmaceuti minus its cost of goods sold. It is profit before Infinity Pharmaceuti operating expenses, interest payments and taxes. Gross profit is also known as gross margin. Aggregate revenue Revenues less cost of revenue [CoR] directly attributable to the revenue generation activity.Infinity Pharmaceuti's Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Infinity Pharmaceuti's overall financial position and show how it may be relating to other accounts over time.
There are typically three primary documents that fall into the category of financial statements. These documents include Infinity Pharmaceuti income statement, its balance sheet, and the statement of cash flows. Infinity Pharmaceuti investors use historical funamental indicators, such as Infinity Pharmaceuti's Gross Profit, to determine how well the company is positioned to perform in the future. Although Infinity Pharmaceuti investors may use each financial statement separately, they are all related. The changes in Infinity Pharmaceuti's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Infinity Pharmaceuti's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Infinity Pharmaceuti Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Infinity Pharmaceuti. Please read more on our technical analysis and fundamental analysis pages.
Last Reported
Projected for 2022
Gross Profit
1.5 M
1.6 M
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Infinity Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Cambridge, Massachusetts. Infinity Pharmaceuti operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 23 people.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Infinity Pharmaceuti without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Analyst Recommendations Now
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Infinity Pharmaceuti using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.
Build Optimal Portfolios
Align your risk with return expectations
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see the analysis of Infinity Pharmaceuti Correlation against competitors. Note that the Infinity Pharmaceuti information on this page should be used as a complementary analysis to other Infinity Pharmaceuti's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for Infinity Stock analysis
When running Infinity Pharmaceuti price analysis, check to measure Infinity Pharmaceuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infinity Pharmaceuti is operating at the current time. Most of Infinity Pharmaceuti's value examination focuses on studying past and present price action to predict the probability of Infinity Pharmaceuti's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Infinity Pharmaceuti's price. Additionally, you may evaluate how the addition of Infinity Pharmaceuti to your portfolios can decrease your overall portfolio volatility.
Watchlist OptimizationOptimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Positions RatingsDetermine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is Infinity Pharmaceuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Infinity Pharmaceuti. If investors know Infinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Infinity Pharmaceuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Infinity Pharmaceuti is measured differently than its book value, which is the value of Infinity that is recorded on the company's balance sheet. Investors also form their own opinion of Infinity Pharmaceuti's value that differs from its market value or its book value, called intrinsic value, which is Infinity Pharmaceuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Infinity Pharmaceuti's market value can be influenced by many factors that don't directly affect Infinity Pharmaceuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Infinity Pharmaceuti's value and its price as these two are different measures arrived at by different means. Investors typically determine Infinity Pharmaceuti value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Infinity Pharmaceuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.